MeMed Diagnostics ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Provider of machine learning-based diagnostic solutions for infectious diseases.

Health Tech & Life Sciences
Active
Series E Tirat Carmel, Israel Founded 2009
Last updated 2026-07-26
Total raised
$223.4M
Last: Undisclosed Round 2021-08
Stage
Series E
Founded
2009
Headcount
100
HQ
Tirat Carmel, Israel
Sector
Health Tech & Life Sciences

About

MeMed Diagnostics is an Israeli medical technology company that develops and commercializes advanced diagnostic solutions leveraging machine learning to analyze the immune system's response to infections. The company's mission is to transform patient care by decoding the immune system's signals into actionable diagnostics, ensuring the right treatment at the right place and time. Their flagship products, MeMed BV® and MeMed Key®, differentiate between bacterial and viral infections, aiming to reduce inappropriate antibiotic prescriptions and improve patient outcomes. MeMed also develops MeMed Severity™, a host-response test designed to predict severe outcomes in patients with acute infections and suspected sepsis.

Funding history · 11 rounds · $223.4M total

2021-07
E Round $93.0M
★ OurCrowd★ Phoenix Insurance★ La Maison Partners★ Union Tech Ventures
2019-10
Grant $2.8M
2018-08
D Round $70.0M
★ Social Capital★ Ping An Ventures★ Phoenix Insurance★ Foxconn Technology Group
2017-09
Grant $4.1M
2016-12
Grant $10.0M
2016-08
Grant $2.6M
2015-07
C Round $27.0M
2015-06
Grant $3.3M
2013-10
Grant $2.0M
2013-07
B Round $6.3M
★ Horizons Ventures★ Social Plus Capital★ Western Technology Investment
2011-08
Seed $2.4M

Headcount over time

From 39 (2018-08) to 97 (2026-03) · +58 (+149%) · 57 points · source: Finder history + radar grounding
1440 2018-08 2026-03

Q&A

What is MeMed Diagnostics' primary focus?
MeMed Diagnostics is an Israeli medical technology company that develops and commercializes advanced diagnostic solutions leveraging machine learning to analyze the immune system's response to infections, primarily to differentiate between bacterial and viral infections.
When was MeMed Diagnostics founded?
MeMed Diagnostics was founded in June 2009.
What is the current employee count for MeMed Diagnostics?
MeMed Diagnostics has 51–200 employees.
What was MeMed Diagnostics' most recent funding round?
MeMed Diagnostics raised a $93,000,000 E Round in 2022. Key investors included Horizons Ventures and Shavit Capital.
What was the total amount of funding MeMed Diagnostics has raised to date?
MeMed Diagnostics has raised a total of $230,006,385 USD.
What is MeMed Diagnostics' flagship product for differentiating infections?
MeMed Diagnostics' flagship product, MeMed BV®, differentiates between bacterial and viral infections.
When did MeMed Diagnostics receive FDA clearance for MeMed BV?
In September 2021, MeMed Diagnostics was granted 510(k) clearance by the FDA for MeMed BV for adults and children.
What is MeMed Key?
MeMed Key is a platform being developed by MeMed Diagnostics that will enable the measurement of multiple proteins and signatures with central lab precision at the point of care, including MeMed BV within minutes.
What is MeMed Severity™?
MeMed Severity™ is a host-response test developed by MeMed Diagnostics designed to predict severe outcomes in patients with acute infections and suspected sepsis.
What was a significant partnership for MeMed Diagnostics in 2020?
In September 2020, DiaSorin and MeMed Diagnostics partnered to develop and commercialize a novel host immune response-based diagnostics solution.

Team · 2

Eran Eden
Founder · Co-founder and CEO
Kfir Oved
Founder · Co-founder and CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision SupportMedical DevicesDiagnostics Devices
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

bioconvergenceinflammatory-diseaseshealthcare-providersmedical-devicesdiagnosticsinfectious-diseaselaboratoriesimmunologypersonalized-medicineartificial-intelligencedecision-makingdigital-healthcarebacteriabioinformaticsmachine-learningbabiesclinicsearly-detectionblood-test
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteme-med.com
LinkedInlinkedin.com/company/2500897
Facebookfacebook.com/Memed.diagnostics

Identifiers & details

Legal nameMEMEDS LTD
Founded2009-6
Employees (exact)100

Radar intelligence

Patents

EPO28

Web history (Wayback)

Domainme-med.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514288885
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2009-06-28
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens1
Registry events3 — shares_capital (1), people (1), charge (1)
Registered addressחת נחום 7 טירת כרמל

Recent registry events

DateEvent
2025-12-31העברת מניות
2026-06-29עדכון בעלי תפקידים
2026-03-16רישום שעבוד